Page last updated: 2024-09-03

n-benzyladriamycin-14-valerate and Cardiomyopathies, Primary

n-benzyladriamycin-14-valerate has been researched along with Cardiomyopathies, Primary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, C; Hofmann, PA; Lothstein, L; Morrison, RR1

Other Studies

1 other study(ies) available for n-benzyladriamycin-14-valerate and Cardiomyopathies, Primary

ArticleYear
Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198).
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:1

    Topics: AMP-Activated Protein Kinase Kinases; Animals; Antibiotics, Antineoplastic; Blotting, Western; Calcium; Cardiomyopathies; Cardiotonic Agents; Doxorubicin; Electrophoresis, Polyacrylamide Gel; Indicators and Reagents; Male; Mass Spectrometry; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Phosphorylation; Poly Adenosine Diphosphate Ribose; Protein Kinase C-epsilon; Protein Kinases; Rats; Rats, Wistar

2010